Orgenesis Stock Shares Outstanding
Orgenesis fundamentals help investors to digest information that contributes to Orgenesis' financial success or failures. It also enables traders to predict the movement of Orgenesis OTC Stock. The fundamental analysis module provides a way to measure Orgenesis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Orgenesis otc stock.
Orgenesis |
Orgenesis OTC Stock Shares Outstanding Analysis
Orgenesis' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Orgenesis Shares Outstanding | 4.77 M |
Most of Orgenesis' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Orgenesis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Orgenesis has 4.77 M of shares currently outstending. This is 97.36% lower than that of the Biotechnology sector and 95.54% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 99.17% higher than that of the company.
Orgenesis Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Orgenesis' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Orgenesis could also be used in its relative valuation, which is a method of valuing Orgenesis by comparing valuation metrics of similar companies.Orgenesis is currently under evaluation in shares outstanding category among its peers.
Orgenesis Fundamentals
Return On Equity | -7.27 | ||||
Return On Asset | -0.3 | ||||
Operating Margin | (16.54) % | ||||
Current Valuation | 23.01 M | ||||
Shares Outstanding | 4.77 M | ||||
Shares Owned By Insiders | 21.16 % | ||||
Shares Owned By Institutions | 4.54 % | ||||
Number Of Shares Shorted | 56.25 K | ||||
Price To Earning | 7.52 X | ||||
Price To Book | 1.26 X | ||||
Price To Sales | 15.21 X | ||||
Revenue | 530 K | ||||
Gross Profit | 36.02 M | ||||
EBITDA | (54.07 M) | ||||
Net Income | (64.92 M) | ||||
Cash And Equivalents | 2.3 M | ||||
Cash Per Share | 0.09 X | ||||
Total Debt | 22.62 M | ||||
Debt To Equity | 0.64 % | ||||
Current Ratio | 1.57 X | ||||
Book Value Per Share | (3.30) X | ||||
Cash Flow From Operations | (14.84 M) | ||||
Short Ratio | 2.39 X | ||||
Earnings Per Share | (8.00) X | ||||
Target Price | 6.0 | ||||
Number Of Employees | 146 | ||||
Beta | 1.21 | ||||
Market Capitalization | 10.07 M | ||||
Total Asset | 14.55 M | ||||
Retained Earnings | (176.62 M) | ||||
Working Capital | (12.33 M) | ||||
Current Asset | 5.29 M | ||||
Current Liabilities | 14.92 M | ||||
Net Asset | 14.55 M |
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in price. Note that the Orgenesis information on this page should be used as a complementary analysis to other Orgenesis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Orgenesis OTC Stock
If you are still planning to invest in Orgenesis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Orgenesis' history and understand the potential risks before investing.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |